DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 Print  Email    

Allergan Inc. (AGN) Settles Oklahoma Botox Case During Trial


2/27/2013 7:41:01 AM

Allergan Inc. (AGN) reached a confidential settlement during trial with the mother of a 6-year-old Oklahoma boy who wound up on a ventilator after he was injected with Botox. The mother of Jackson Wells claimed the injection, given to treat spasticity in his legs, caused the boy to develop acute botulism, leaving him unable to breathe on his own. Jessica Wells also claimed Allergan promoted the drug for children despite a lack of regulatory approval for such use. Allergan settled the lawsuit yesterday during trial while the boy’s treating doctor was testifying, said plaintiffs’ lawyer Ray Chester. The trial began Feb. 19 in Oklahoma City federal court. “While the amount is confidential, young Jackson Wells will be well taken care of for life,” Chester said in an interview today. U.S. District Judge Robin J. Cauthron confirmed the settlement in a one-page order yesterday closing the case. Bonnie Jacobs, a spokeswoman for Irvine, California-based Allergan, declined to comment on the settlement.

Read at Bloomberg

 Read Article at  Related Companies  News Categories
Bloomberg
   


ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 
    

//-->